Higher TMB increases neoantigen presentation which promotes lymphocyte infiltration at the tumor periphery and microenvironment.13 Thus high TMB is associated with a higher likelihood of response to PD-1/PD-L1 immune checkpoint inhibitor therapy. Here, CD274 is linked to neoplasm.